ANTI-THYMOCYTE RABBIT IMMUNOGLOBULIN: POSTOPERATIVE RISK FACTOR FOR SIROLIMUS TREATED RENAL TRANSPLANT PATIENTS

Authors :: C. Barcenas
Carlos Benavides
Richard J. Knight
C. T. Van Buren
K. H. Mahmoud
Kahan Bd
Source :: Transplantation. 78:82-83
Publication Year :: 2004
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2004.

Subjects :: Transplantation
medicine.medical_specialty
biology
business.industry
Gastroenterology
Thymocyte
Postoperative risk
Renal transplant
Sirolimus
Internal medicine
biology.protein
medicine
Antibody
business
medicine.drug

Full Text Access

Tools